NDRAENDRA Life Sciences Inc.vs its industry peers
A metric-by-metric comparison of ENDRA Life Sciences Inc. against SIC 3845 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NDRAEsta | $8M#9 | — | 1.3x#3 | — | — | 38.9%#3 | — | -111.4%#6 | — | — | 14.9%#5 | — |
| ECOR | $105M#2 | — | — | 3.3x#7 | 27.2%#6 | -17.5%#7 | -41.1%#8 | — | — | — | 136.1%#3 | — |
| NRXS | $95M#3 | — | 14.1x#6 | 26.6x#8 | 32.9%#5 | 5.4%#6 | -219.4%#11 | -115.8%#7 | — | — | 190.6%#2 | — |
| STEX | $73M#4 | — | 0.5x#1 | 1812.8x#9 | 122.2%#3 | -4379.9%#15 | -177735.0%#14 | -317.8%#9 | — | — | -90.2%#9 | — |
| OM | $59M#5 | — | 0.6x#2 | 0.5x#3 | 5.1%#9 | 36.2%#4 | -55.8%#9 | -84.8%#5 | -40.7%#4 | 4#2 | -77.9%#8 | — |
| POCI | $47M#6 | — | 2.3x#4 | 2.5x#6 | -0.1%#13 | -95.8%#12 | -29.1%#6 | -28.7%#4 | -51.1%#5 | 3#5 | 2.6%#6 | — |
| QTI | $37M#7 | — | 16.7x#7 | 2.0x#4 | 287.9%#2 | -134.6%#13 | -23.4%#5 | -938.7%#10 | -163.2%#7 | 6#1 | 287.9%#1 | — |
| IRIX | $12M#8 | — | 3.2x#5 | 0.2x#1 | 8.2%#7 | 50.2%#2 | -4.9%#3 | -121.9%#8 | -155.0%#6 | 3#5 | -48.7%#7 | — |
| NUWE | $3M#10 | 0.0x#1 | — | 0.4x#2 | -5.4%#14 | -56.9%#11 | -134.3%#10 | — | — | — | -99.3%#10 | — |
| ADMT | — | — | — | — | 4.7%#10 | 18.4%#5 | -4.8%#2 | -16.6%#3 | -36.5%#3 | — | — | — |
| ENDV | — | — | — | — | 85.2%#4 | -495.0%#14 | -2411.7%#13 | — | — | 4#2 | — | — |
| ESMC | — | — | — | — | 0.5%#12 | 184.2%#1 | 1.1%#1 | 2.5%#1 | 16.2%#1 | — | — | — |
| FOCL | $154M#1 | — | — | 2.2x#5 | 1.6%#11 | -42.1%#10 | -35.0%#7 | — | -172.8%#8 | 3#5 | 69.8%#4 | — |
| GTHP | — | — | — | — | 10857.1%#1 | -32.2%#9 | -309.3%#12 | — | — | 4#2 | — | — |
| HCIL | — | — | — | — | 7.1%#8 | -24.7%#8 | -13.4%#4 | -1.1%#2 | -0.8%#2 | 3#5 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3845). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-19.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice